Investments
Building in good company.

Company
Description
Sector
Region
Year Invested
Year Exited

Seaport Therapeutics is a clinical-stage biopharmaceutical company developing neuropsychiatric medicines in areas of unmet patient needs.
View Site
Life Sciences
United States
2024
1970

Verdiva Bio is a clinical-stage biopharmaceutical company focused on developing innovative therapies for obesity and other cardiometabolic disorders.
View Site
Life Sciences
EMEA
2024
1970

WuXi XDC provides single-source discovery, development & manufacturing services for antibody drug conjugates and other novel bioconjugates.
View Site
Life Sciences
China
2023
2024

Akero Therapeutics is a clinical stage biotechnology company developing novel therapies for patients with non-alcoholic steatohepatitis.
View Site
Life Sciences
United States
2023
1970

Acelyrin is a late-stage clinical biotech company focused on acquiring and accelerating the development of immunology medicines.
View Site
Life Sciences
United States
2023
1970

Karuna Therapeutics is a clinical-stage biotech company developing a novel drug for schizophrenia and Alzheimer’s Disease related psychosis.
View Site
Life Sciences
United States
2022
2024

LePure is a provider of single-use bioprocess solutions for biopharmaceutical companies in China.
View Site
Life Sciences
China
2022
1970

Javara is an integrated research organization that partners with healthcare providers to conduct clinical trials.
View Site
Life Sciences
United States
2022
1970

WuXi Biologics a contract development and manufacturing organization that provides outsourcing services for pharmaceutical and biotechnology companies in all stages of the biologics development process.
View Site
Life Sciences
China
2022
1970

Solve Therapeutics is a biopharmaceutical company that develops next-gen antibody-drug conjugates and bispecific therapeutics for cancer.
View Site
Life Sciences
United States
2021
1970

Third Harmonic Bio is a clinical stage biotechnology company developing an oral KIT inhibitor therapy for allergic autoimmune disorders.
View Site
Life Sciences
United States
2021
2025

Ultima Genomics focuses on developing next-generation genome sequencing technology for the high-volume research and clinical markets.
View Site
Life Sciences
United States
2021
1970

CinCor Pharma is a clinical-stage biopharmaceutical company with a mission to bring innovation to the treatment of hypertension.
View Site
Life Sciences
United States
2021
2023

Genesis MedTech is a medical technology and device platform focused on the emerging markets.
View Site
Life Sciences
China
2021
1970

Biotheus is a clinical development stage company treating cancer and autoimmune diseases through next-generation therapeutics.
View Site
Life Sciences
EMEA
2021
1970

Centessa Pharmaceuticals is a next-gen biopharmaceutical company reshaping traditional drug development with its asset-centric R&D model.
View Site
Life Sciences
United States
2021
1970

KGBio is a clinical-stage biotech company focused on the in-licensing, clinical development, and manufacturing of biological products.
View Site
Life Sciences
Southeast Asia
2021
1970

Pharvaris is a clinical-stage company focused on the discovery and development of treatments for hereditary angioedema.
View Site
Life Sciences
EMEA
2020
1970

HUTCHMED is a biopharmaceutical company focused on discovering, developing, and commercializing cancer and immunology therapies.
View Site
Life Sciences
China
2020
1970

CANbridge is a biotechnology company focused on developing and commercializing rare disease therapeutics in China.
View Site
Life Sciences
China
2020
2024

SciNeuro is a clinical-stage biotechnology company that develops innovative medicines for patients with central nervous system diseases.
View Site
Life Sciences
China
2020
1970

Royalty Pharma is an innovative biopharma company with a portfolio of commercial and pre-commercial drug royalties.
View Site
Life Sciences
United States
2020
1970

Adagene is a clinical-stage biotechnology company focused on developing innovative antibodies with superior safety and efficacy profiles.
View Site
Life Sciences
China
2019
1970

Allonnia engineers breakthrough systems to develop and commercialize new waste remediation and management solutions.
View Site
Life Sciences
United States
2019
1970